Switch theme
Sign up to access all valuation multiples
OssDsign AB is a developer and global provider of next-generation orthobiologics products. The company's product OssDsign Catalyst is a bone graft that stimulates the formation of healthy bone tissue in spinal fusion surgeries. Geographically the company generates revenue from the US, Germany, Sweden, the UK, the Rest of Europe, and the Rest of world. The company generates the majority of its revenue from the US.
2011
27
LTM Revenue $15.9M
LTM EBITDA -$4.0M
$135M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
OssDsign has a last 12-month revenue (LTM) of $15.9M and a last 12-month EBITDA of -$4.0M.
In the most recent fiscal year, OssDsign achieved revenue of $13.8M and an EBITDA of -$4.3M.
OssDsign expects next 12-month revenue of XXX and NTM EBITDA of XXX
See OssDsign valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $15.9M | XXX | $13.8M | XXX | XXX | XXX |
| Gross Profit | $15.1M | XXX | $13.2M | XXX | XXX | XXX |
| Gross Margin | 95% | XXX | 95% | XXX | XXX | XXX |
| EBITDA | -$4.0M | XXX | -$4.3M | XXX | XXX | XXX |
| EBITDA Margin | -25% | XXX | -31% | XXX | XXX | XXX |
| EBIT | -$4.5M | XXX | -$5.1M | XXX | XXX | XXX |
| EBIT Margin | -28% | XXX | -37% | XXX | XXX | XXX |
| Net Profit | -$4.7M | XXX | -$5.1M | XXX | XXX | XXX |
| Net Margin | -30% | XXX | -37% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, OssDsign's stock price is SEK 14 (or $1).
OssDsign has current market cap of SEK 1.4B (or $145M), and EV of SEK 1.3B (or $135M).
See OssDsign trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $135M | $145M | XXX | XXX | XXX | XXX | $-0.04 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, OssDsign has market cap of $145M and EV of $135M.
OssDsign's trades at 9.8x EV/Revenue multiple, and -31.1x EV/EBITDA.
Equity research analysts estimate OssDsign's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
OssDsign has a P/E ratio of -30.9x.
See valuation multiples for OssDsign and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $145M | XXX | $145M | XXX | XXX | XXX |
| EV (current) | $135M | XXX | $135M | XXX | XXX | XXX |
| EV/Revenue | 8.5x | XXX | 9.8x | XXX | XXX | XXX |
| EV/EBITDA | -33.7x | XXX | -31.1x | XXX | XXX | XXX |
| EV/EBIT | -30.2x | XXX | -26.5x | XXX | XXX | XXX |
| EV/Gross Profit | 8.9x | XXX | n/a | XXX | XXX | XXX |
| P/E | -30.9x | XXX | -28.3x | XXX | XXX | XXX |
| EV/FCF | -22.1x | XXX | -20.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialOssDsign's last 12 month revenue growth is 31%
OssDsign's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.7M for the same period.
OssDsign's rule of 40 is -60% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
OssDsign's rule of X is 53% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for OssDsign and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 31% | XXX | 31% | XXX | XXX | XXX |
| EBITDA Margin | -25% | XXX | -31% | XXX | XXX | XXX |
| EBITDA Growth | -42% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | -60% | XXX | 0% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 53% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.5M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.7M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 80% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 17% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 132% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
OssDsign acquired XXX companies to date.
Last acquisition by OssDsign was XXXXXXXX, XXXXX XXXXX XXXXXX . OssDsign acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was OssDsign founded? | OssDsign was founded in 2011. |
| Where is OssDsign headquartered? | OssDsign is headquartered in Sweden. |
| How many employees does OssDsign have? | As of today, OssDsign has 27 employees. |
| Is OssDsign publicy listed? | Yes, OssDsign is a public company listed on STO. |
| What is the stock symbol of OssDsign? | OssDsign trades under OSSD ticker. |
| When did OssDsign go public? | OssDsign went public in 2019. |
| Who are competitors of OssDsign? | Similar companies to OssDsign include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of OssDsign? | OssDsign's current market cap is $145M |
| What is the current revenue of OssDsign? | OssDsign's last 12 months revenue is $15.9M. |
| What is the current revenue growth of OssDsign? | OssDsign revenue growth (NTM/LTM) is 31%. |
| What is the current EV/Revenue multiple of OssDsign? | Current revenue multiple of OssDsign is 8.5x. |
| Is OssDsign profitable? | Yes, OssDsign is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of OssDsign? | OssDsign's last 12 months EBITDA is -$4.0M. |
| What is OssDsign's EBITDA margin? | OssDsign's last 12 months EBITDA margin is -25%. |
| What is the current EV/EBITDA multiple of OssDsign? | Current EBITDA multiple of OssDsign is -33.7x. |
| What is the current FCF of OssDsign? | OssDsign's last 12 months FCF is -$6.1M. |
| What is OssDsign's FCF margin? | OssDsign's last 12 months FCF margin is -39%. |
| What is the current EV/FCF multiple of OssDsign? | Current FCF multiple of OssDsign is -22.1x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
